Efficacy and safety of nirsevimab for preventing respiratory syncytial virus infection in infants: an updated systematic review and meta-analysis encompassing 11,001 participants
Nirsevimab shows promise in preventing RSV infections and hospitalizations, warranting further study on its practicality and cost-effectiveness.
Authors
- Mohamed Abuelazm (ORCID: https://orcid.org/0000-0002-2514-0689)
- AlMothana Manasrah (ORCID: https://orcid.org/0009-0001-6266-4991)
- Mohamed Abouzid (ORCID: https://orcid.org/0000-0002-8917-671X)
- Mohammad Tanashat (ORCID: https://orcid.org/0000-0002-8819-1803)
- Obieda Altobaishat (ORCID: https://orcid.org/0000-0001-7213-0507)
- Noor M. Masadeh
Institutions
- Poznan University of Medical Sciences (PL)
- Jordan University of Science and Technology (JO)
- Tanta University (EG)
- Jordan Hospital (JO)
- WinnMed (US)
- Yarmouk University (JO)
Publication Details
- Journal
- Baylor University Medical Center Proceedings
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1080/08998280.2025.2488211
- Citations
- 3
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 4.06